Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1966 1
1967 1
1968 1
1971 2
1978 2
1980 1
1982 1
1983 2
1987 1
1988 1
1989 4
1990 5
1991 1
1992 3
1993 3
1994 2
1995 4
1996 1
1997 2
1998 2
1999 5
2000 5
2001 1
2002 5
2003 5
2004 7
2005 14
2006 18
2007 21
2008 30
2009 18
2010 25
2011 31
2012 23
2013 35
2014 33
2015 37
2016 58
2017 51
2018 52
2019 47
2020 51
2021 57
2022 61
2023 62
2024 46
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

772 results

Results by year

Filters applied: . Clear all
Page 1
Enzyme engineering and its industrial applications.
Victorino da Silva Amatto I, Gonsales da Rosa-Garzon N, Antônio de Oliveira Simões F, Santiago F, Pereira da Silva Leite N, Raspante Martins J, Cabral H. Victorino da Silva Amatto I, et al. Among authors: cabral h. Biotechnol Appl Biochem. 2022 Apr;69(2):389-409. doi: 10.1002/bab.2117. Epub 2021 Feb 25. Biotechnol Appl Biochem. 2022. PMID: 33555054 Review.
Outcomes After Dose Intensification of Risankizumab for Crohn's Disease.
Dalal RS, Cabral HJ, Carlin A, Ilse MP, Allegretti JR. Dalal RS, et al. Among authors: cabral hj. Clin Gastroenterol Hepatol. 2025 Mar;23(4):662-664.e1. doi: 10.1016/j.cgh.2024.09.039. Epub 2024 Dec 9. Clin Gastroenterol Hepatol. 2025. PMID: 39662691 No abstract available.
Nanomedicine for brain cancer.
Quader S, Kataoka K, Cabral H. Quader S, et al. Among authors: cabral h. Adv Drug Deliv Rev. 2022 Mar;182:114115. doi: 10.1016/j.addr.2022.114115. Epub 2022 Jan 22. Adv Drug Deliv Rev. 2022. PMID: 35077821 Review.
Aspergillus fumigatus conidial surface-associated proteome reveals factors for fungal evasion and host immunity modulation.
Pinzan CF, Valero C, de Castro PA, da Silva JL, Earle K, Liu H, Horta MAC, Kniemeyer O, Krüger T, Pschibul A, Cömert DN, Heinekamp T, Brakhage AA, Steenwyk JL, Mead ME, Hermsdorf N, Filler SG, da Rosa-Garzon NG, Delbaje E, Bromley MJ, Cabral H, Diehl C, Angeli CB, Palmisano G, Ibrahim AS, Rinker DC, Sauters TJC, Steffen K, Gumilang A, Rokas A, Gago S, Dos Reis TF, Goldman GH. Pinzan CF, et al. Among authors: cabral h. Nat Microbiol. 2024 Oct;9(10):2710-2726. doi: 10.1038/s41564-024-01782-y. Epub 2024 Aug 27. Nat Microbiol. 2024. PMID: 39191887 Free PMC article.
Remodeling tumor microenvironment with nanomedicines.
Martin JD, Miyazaki T, Cabral H. Martin JD, et al. Among authors: cabral h. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1730. doi: 10.1002/wnan.1730. Epub 2021 Jun 14. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 34124849 Review.
Nanomedicine-Based Approaches for mRNA Delivery.
Uchida S, Perche F, Pichon C, Cabral H. Uchida S, et al. Among authors: cabral h. Mol Pharm. 2020 Oct 5;17(10):3654-3684. doi: 10.1021/acs.molpharmaceut.0c00618. Epub 2020 Sep 8. Mol Pharm. 2020. PMID: 32845639 Review.
Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P, Cabral H, Kataoka K. Mi P, et al. Among authors: cabral h. Adv Mater. 2020 Apr;32(13):e1902604. doi: 10.1002/adma.201902604. Epub 2019 Jul 28. Adv Mater. 2020. PMID: 31353770 Review.
772 results